Ardelyx (ARDX) Net Margin (2013 - 2026)

Ardelyx (ARDX) posted Net Margin of 39.81% for Q1 2026, down 12146.16% on a QoQ basis from 0.33% in Q4 2025, and up 1571.0% year-over-year from 2.38% in Q1 2025.

Ardelyx (ARDX) Net Margin (2013 - 2026) Analysis & Trends

Ardelyx's Net Margin history runs 12 years deep, the most recent figure standing at 39.81% for Q1 2026.

  • Quarterly Net Margin rose 1571.0% year-over-year to 39.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.1% (down 324.0% YoY) and the FY2025 annual result came in at 15.12%, down 339.0% from the prior year.
  • Net Margin was 39.81% for Q1 2026 at Ardelyx, down from 0.33% in the prior quarter.
  • Across five years, Net Margin topped out at 24.21% in Q4 2022 and bottomed at 5998.08% in Q1 2022.
  • A 5-year average of 476.72% and a median of 39.81% in 2026 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin sank 549435 bps — and 2023, when it jumped 576259 bps.
  • Ardelyx's Net Margin stood at 24.21% in 2022, then slumped by 446 bps to 83.82% in 2023, then jumped by 105 bps to 4.0% in 2024, then slumped by 108 bps to 0.33% in 2025, then slumped by 12146 bps to 39.81% in 2026.
  • Business Quant data shows ARDX's Net Margin at 39.81% in Q1 2026, 0.33% in Q4 2025, and 28.5% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn -39.81%

Historic Data

Download Data
DateValue
Mar 31, 2026 -39.81%
Dec 31, 2025 -0.33%
Sep 30, 2025 -28.50%
Jun 30, 2025 -19.54%
Mar 31, 2025 -55.51%
Dec 31, 2024 4.00%
Sep 30, 2024 -0.82%
Jun 30, 2024 -22.47%
Mar 31, 2024 -57.62%
Dec 31, 2023 -83.82%
Sep 30, 2023 11.76%
Jun 30, 2023 -76.66%
Mar 31, 2023 -235.49%
Dec 31, 2022 24.21%
Sep 30, 2022 -459.15%
Jun 30, 2022 -1,066.43%
Mar 31, 2022 -5,998.08%
Dec 31, 2021 -3,521.28%
Sep 30, 2021 -3,715.86%
Jun 30, 2021 -3,441.66%